Addition of anticholinergic solution prolongs bronchodilator effect of β2agonists in patients with chronic obstructive pulmonary disease
References (33)
- et al.
Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD
Chest
(1989) - et al.
Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction
Respiratory Medicine
(1990) Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD
Chest
(1991)- et al.
Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room
Am J Med
(1987) - et al.
A comparison of the effects of anticholinergic and betaz-agonist and combination therapy on respiratory impedance in COPD
Chest
(1992) - et al.
Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients
Chest
(1987) - et al.
Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction
Chest
(1988) - et al.
Measuring functional status in chronic lung disease: conclusions from a randomized control trial
Respir Med
(1989) - et al.
Tolerance to beta2-agonists in patients with chronic obstructive pulmonary disease
Chest
(1990) - et al.
Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma
Chest
(1992)
Automatic regulation of the airways
Annu Rev Med
(1984)
Aerosol Sch 1000: an anticholinergic Bronchodilator
Am Rev Respir Dis
(1975)
Role of the parasympathetic system in airway obstruction due to emphysema
N Engl J Med
(1984)
Use of ipratropium bromide in obstructive lung disease
Clin Pharm
(1988)
Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease
Am J Med
(1991)
Drug treatment of COPD: controversies about agents and how to deliver them
Postgrad Med
(1992)
Cited by (0)
Copyright © 1996 Published by Excerpta Medica Inc.